Melanin has been reported to be the key factor for skin homeostasis. Besides defining an important human phenotypic trait, melanin overproduction may cause various disorders such as vitiligo, Addison's disease, Cushing's syndrome, and melasma. In this study, we aimed to investigate the anti-melanogenic potential of dried spike extract of chestnut. The extract inhibited tyrosinase (TYR) activity in a dose-dependent manner. Cellular melanin content decreased markedly after treatment with the extract. The spike extract inhibited microphthalmia-associated transcription factor (MITF) expression and downregulated TYR, TYRP-1, and TYRP-2 protein expression by increasing the phosphorylation of extracellular signal-regulated kinase (ERK)1/2 signalling pathway in melan-a cells. In addition, treatment with U0126, a specific inhibitor of ERK, restored melanin content. Collectively, these results suggest that the chestnut spike extract attenuated melanogenesis by inhibiting MITF expression and downregulating TYR, TYRP-1, and TYRP-2 protein expressions via activation of ERK1/2 pathway.
Melanin is a pigment that is biosynthesized within melanosomes of melanocytes and transferred to the neighbouring keratinocytes. It plays a pivotal role not only in determining the skin colour, but also in protecting our skin from ultraviolet irradiation (UVR) [1] . However, abnormal melanin production leads to various skin disorders such as lentigo, leucocytosis, vitiligo, melasma, and moles [2] . Therefore, regulation of melanogenesis is important in the treatment of abnormal pigmentation of the skin. Melanin synthesis is controlled by melanin-producing enzymes such as tyrosinase (TYR), TYRP-1, and TYRP-2 [3] . Tyrosinase is a rate-limiting enzyme in melanin production, and therefore, inhibition of tyrosinase activity was used to screen skin whitening agents [4, 5] . Mounting evidences suggest that UV-induced melanin biosynthesis leads to incessant production of reactive oxygen species (ROS), including superoxide radicals, hydroxyl radicals, and hydrogen peroxide (H 2 O 2 ) in melanocytes [6] . Recent research revealed that the increase in ROS production induced by UVR is associated with increase in melanin production via increasing tyrosinase activity in melanocytes. Several studies have shown that mitogen-activated protein kinase (MAPK) signalling pathways play a key role in regulating melanogenesis [7] . Extracellular signal-regulated kinase (ERK1/2) and c-Jun N terminal kinase (JNK) are involved in melanogenesis via downregulation of tyrosinase-related proteins, sustained ERK 1/2 activation, and subsequent microphthalmiaassociated transcription factor (MITF) [8, 9] .
Castanea crenata, commonly known as chestnut, belongs to the family Fagaceae and is a woody plant abundant in Korea and Japan. It is also cultivated in different countries in Asia [10] . These species have traditionally been used as a medicine to treat various ailments in countries such as China and India [11] . The endothelium of C. crenata has been used as an anti-wrinkling agent and skin moisturizer for many years in East Asia [12] . The fruit and leaves of chestnut are rich in polyphenolics [13] . Recent data showed that tannin is relatively abundant in chestnut inner shell extract [14] , and chestnut endothelial extract may have the potential to inhibit melanin biosynthesis [15] . However, the anti-melanogenic potential of chestnut husk has not yet been elucidated. Chestnut husk comprises spikes and crusts supporting the spikes ( Figure 1A ). In the present study, we aimed to evaluate the activities of chestnut spike extract against melanin biosynthesis and to elucidate the underlying molecular mechanisms in melan-a cells.
High performance liquid chromatography (HPLC) analysis was performed with standard phenolic and flavonoid compounds to gain insight into the phytochemicals present in C. crenata spike extract. In this study, we found that the spike extract contains gallic acid (5.65), catechin (12.31), caffeic acid (14.92), syringic acid (15.12), rutin (17.27), ferulic acid (19.16) and naringin (19.29) ( Figure 1B) . The three compounds commonly found in the chestnut extracts are gallic acid, syringic acid, and rutin. In silico analysis was carried out to obtain the biological activity spectra of the major compounds in spike extract. PASS predictions are based on the structuralactivity relationship analysis of training sets that contain more than 205,000 compounds, including more than 3,750 species [16] . In PASS analysis, the structures of phytochemical compounds are compared with those of well-known biologically active materials, and the results reveal whether a phytochemical compound has a NPC Natural Product Communications specific effect [17] . The predicted activities of compounds in spike extract include free radical scavenging, antioxidation, kinase inhibition, and skin whitening effects. Skin whitening-related activities, such as MAPK stimulation and melanin inhibition, were predicted for chestnut spike extract. These results collectively predict the antioxidant and anti-whitening activities of the extract. The predicted results were clearly expressed as the percentage of expected probability of activity (Pa) and inactivity (Pi). The values of Pa ranged from 0.709 to 0.988, while those of Pi ranged from 0.001 to 0.014. These results indicate that all seven polyphenol compounds are involved in various functionalities.
Next, the activity of tyrosinase, an enzyme that plays a major role in melanin formation, was measured by spectroscopic analysis. Tyrosinase converts L-tyrosine to L-DOPA and oxidizes L-DOPA to L-DOPAchrome. Thus, inhibition of tyrosinase activity is an important indicator for evaluating skin whitening effects [18] . Mushroom tyrosinase is widely used as a target enzyme for screening melanogenesis inhibitors [19] . The activity of spike extract increased in a concentration-dependent manner ( Figure 2A , columns 7~10). MTT assay was performed to evaluate the cytotoxicity of spike extract. The results showed that the sample was not cytotoxic to melan-a cells at concentrations below 30 μg/mL. Therefore, we decided to use a maximum spike extract concentration of 30 μg/mL for cell experiments (data not shown). Melanin production takes place in organelles called melanosomes [20] . It is an important pigment that protects the skin from external factors such as UV light and determines the skin colour. The production of melanin is a complex process involving various enzyme-catalysed chemical reactions and signalling pathways. Melanin content was determined to investigate the effect of spike extract on melanin production. As shown in Figure 2B , melanin content decreased with increasing concentrations of spike extract. Reverse transcription polymerase chain reaction (RT-PCR) was performed to investigate the effect of spike extract on the expression of genes involved in melanin biosynthetic pathway in melan-a cells. The inhibition of expression of TYR, MITF, TYRP-1, and TYRP-2, which are important proteins/enzymes in melanin biosynthesis, was confirmed at the mRNA level. The expression of each gene decreased with increasing concentrations of spike extract ( Figure 3A ). The mRNA expression was found to be lower when treated with 30 μg/mL spike extract than with 300 μg/mL control.
The protein expression levels of TYR, TYRP-1, TYRP-2, and MITF was confirmed by western blotting. Spike extract showed a concentration-dependent decrease in TYR, TYRP-1, TYRP-2, and MITF protein expression ( Figure 3B ). Therefore, we suggest that melanin synthesis inhibition may be due to the inhibition of TYR, TYRP-1, TYRP-2, and MITF protein expression by spike extract. MITF, an important transcriptional regulator in melanin synthesis, is known to promote the transcription of TYR, TYRP-1, and TYRP-2 [21] . Phosphorylated-ERK induces phosphorylation of serine-73 residue of MITF, resulting in ubiquitination of MITF and proteasomal degradation, and consequently, inhibition of melanin synthesis [22] . To elucidate the mechanism underlying the antimelanogenic activity of spike extract, we determined the level of MAPK signalling molecules in melan-a cells by western blotting. Recently, it was reported that melanin biosynthesis is regulated by ERK1/2, an intracellular signalling protein [22] . We confirmed that spike extract expressed ERK1/2 in melan-a cells ( Figure 3C ). ERK1/2 phosphorylation was examined at the non-toxic concentration of 30 g/mL of spike extract. We found that high ERK1/2 phosphorylation occurred at 30 min after treatment with spike extract and at 6 h after treatment with spike extract. In contrast, JNK and p38 were not affected by spike extract in melan-a cells (data not shown). These results indicate that spike extract inhibits melanogenesis via ERK1/2 signalling pathway.
To determine whether increased phosphorylation of ERK1/2 is involved in inhibition of MITF expression, the cells were pretreated with the ERK1/2 inhibitor U0126 before treatment with spike extract. Treatment with U0126 inactivated MITF and inhibited tyrosinase activity, which in turn resulted in the inhibition of melanin production (data not shown). These results indicate that activation of ERK1/2 pathway is involved in the reduction of melanin production by spike extract. To investigate the effect of spike extract on melanogenesis further, intracellular tyrosinase activity of melan-a cells was measured using L-DOPA zymography.
Anti-melanogenic potential by chestnut spike extract
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Treatment with spike extract at concentrations ranging from 0.3-30 μg/mL increased tyrosinase inhibition ( Figure 3D ). These results suggest that spike extract inhibits melanin production in melan-a cells.
In conclusion, we demonstrated that spike extract of Castanea crenata can potentially downregulate the expression of TRP-related proteins and activate ERK 1/2 proteins. We anticipate that spike extract can be added as an ingredient to products from the cosmetic, cosmeceutical, and/or functional food industries to prevent melanogenesis. Figure 1A ). The spikes of chestnut were washed and dried at 37°C for one day. The dried spikes were pulverized into a fine powder. The powder was refluxed with 70% ethanol at 60°C for 12 h, and the extract was filtered through a filter paper. The supernatant was then collected and freeze-dried. Finally, lyophilized spike extract was dissolved in 100 mg/mL of dimethyl sulfoxide (DMSO).
Experimental
HPLC analysis:
The separation of phenolic compounds was performed on a high-performance liquid chromatograph as described previously [18] . Aqua 5 μm C18 column (250 x 4.6 mm I.D.) was used and operated at 30ºC. The binary mobile phase comprised acetonitrile (solvent A) and water containing 2% acetic acid (solvent B). The samples were injected at a volume of 10 μL for measurement by simultaneous monitoring at 280 nm.
Biological spectrum in silico: Different compounds of spike extract were compared to determine whether activity and inactivity can be predicted by using a software. Therefore, we used prediction of activity spectra for substances tool (PASS, available http://www. pharmaexpert.ru /PASSonline/index.php). The major compounds (caffeic acid, catechin, ferulic acid, gallic acid, rutin, syringic acid, and naringin) identified via HPLC were subjected to computerized screening for possible biological effects [16] .
Measurement of tyrosinase activity: Sodium phosphate buffer (0.1 M, pH 6.4) was used for tyrosinase reaction. The enzyme used was 200 U/mL mushroom tyrosinase (EC: 1.14.18.1., 200 units/mL in 0.1 M sodium phosphate buffer, pH 6.4), and the substrate was 1 mM of L-tyrosine. Then, 2 μL of spike extract was added to a 96-well microplate (SPL, Pocheon, Korea), followed by the addition of 100 μL of enzyme and 100 μL of substrate. Arbutin was used as a positive control.
Cell culture and cell viability assay: The mouse melanocyte cell line melan-a was obtained from Dorthy C. Bennett. (St George's, University of London, London, UK). Melan-a cells were cultured in media supplemented with TPA (200 nM), 10% foetal bovine serum, and streptomycin-penicillin. Melan-a cells were cultured in an incubator with 5% CO 2 at 37°C. The cells were sub-cultured every four days until they reached a maximum of 40 passages. Cell viability was determined using the MTT assay kit. Melan-a cells (1 × 10⁵ cells/mL) were cultured in 96-well microplates for one day, washed once with phosphate-buffered saline (PBS), and treated with spike extract at various concentrations. After 24 h of culture, the medium was removed, and the cells were treated with 100 μM MTT solution and cultured for 1 h at 37°C. After removal of medium, the microplate was washed once with PBS. Then, formazan crystals were dissolved in DMSO. Cell viability was confirmed by measuring the absorbance of insoluble formazan product with a microplate reader (VICTOR3) at 595 nm.
Analysis of mRNA expression and western blotting: Total RNA was extracted using TRIzol reagent (Invitrogen) according to manufacturer's instructions with a slight modification [23] . For isolation of RNA, melan-a cells (5 × 10⁵ cells/mL) were cultured in a 6-well microplate and treated with 30 μL spike extract for 24 h. After removal of medium, total RNA was isolated using TRIzol reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's protocol. Reverse transcription for cDNA was performed using Oligo dT, DTT, Master mix, and total RNA. cDNA was amplified by PCR for one cycle each of 5 min at 94°C; 30 s at 94°C, 30 s at 56°C, and 1 min at 72°C for 30 cycles, followed by a 10-min elongation cycle at 72°C using a PCR Thermal Cycler Dice TP600 (TaKaRa Bio Inc., Otsu, Japan). The following oligonucleotide primers were used: mouse tyrosinase (forward, 5′-CCC AGA AGC CAA TGC ACC TA-3′; reverse, 5′-ATA ACA GCT CCC ACC AGT GC-3′); TYRP-1 (forward, 5′-GCT GCA GGA GCC TTC TTT CT-3′; reverse, 5′-AGA CGC TGC ACT GCT GGT C-3′); TYRP-2 (forward, 5′-GGA TGA CCG TGA GCA ATG GC-3′; reverse, 5′-CGG TTG TGA CCA ATG GGT GC-3′); MITF (forward, 5′-CAG GCT AGA GCG CAT GGA CT-3′; reverse, 5′-CTC CGT TTC TTC TGC GCT CA-3′), and GAPDH (forward, 5′-GCG AGA CCC CAC TAA CAT CA-3′; reverse, 5′-GAG TTG GGA TAG GGC CTC TCT T-3′). The amplified cDNA was electrophoresed using 1% agarose gel and detected by Image Lab software (ChemiDoc, Bio-Rad Laboratories, USA). Western blot analysis was performed to investigate protein expression and signal transduction pathways after treatment with spike extract. Melan-a cells (5 × 10⁵ cells/mL) were cultured in a 6-well microplate for 24 h. Each well was treated with 0.3, 3, or 30 μg/mL spike extract at various times (0.25, 0.5, 1, or 3 h). Then, the medium was removed, and the wells were washed with PBS. The proteins in each well were extracted with lysis buffer (RIPA: protease inhibitor cocktail: phosphatase inhibitor cocktail=1 mL:10 μL:10 μL). The extracted proteins were quantitated using BCA kit. The quantified proteins were transferred to nitrocellulose membranes after sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). The membranes were blocked with 5% skim milk or 5% bovine serum albumin (BSA) for 1 h and then incubated for 12 h with primary antibodies against the target protein. Then, secondary antibody was added and incubated for 2 h, and analysed using Image Lab software.
Analysis of melanin content and tyrosinase zymography:
Melan-a cells (1 × 10⁵ cells/mL) were cultured in a 24-well microplate for one day. After replacing with fresh medium, the spike extract was treated at various concentrations by 10 μL. After repeating this process for three days, the medium was removed and the wells were washed once with PBS. Then, 250 μL of 1 N NaOH was added and incubated at 70°C for 15 min, followed by transfer to a 96-well microplate. The absorbance was measured at 405 nm using VICTOR3. For zymography, melan-a cells (1 × 10⁵ cells/mL) were cultured in a 6-well microplate for one day. Spike extract was treated at a concentration of 30 μL per well, and this procedure was repeated for three days. After removal of medium, the cells were washed with PBS, and proteins were extracted using RIPA cell lysis buffer. Proteins were quantified using a BCA protein assay kit. The extracted proteins were separated using 10% SDS-PAGE. The gel was incubated with 0.1 M phosphate buffer (pH 6.8) solution for 2 min with shaking for 30 min, and then stained with 20 mM L-DOPA in 0.1 M sodium phosphate buffer (pH 6.8) for 1 h at 37°C.
Statistical analysis:
The experimental data are presented as the mean ± standard deviation (SD). Data were analysed using a paired Student's t-test. Differences were considered significant if p ≤ 0.05 or p ≤ 0.01. All analyses were carried out using SPSS, version 23.0 (Chicago, IL, USA).
